CIRM grants $5.

CIRM grants $5.6 million to develop HIV/Helps therapeutic using Sangamo’s ZFN genome-editing technology Sangamo BioSciences, Inc. announced that the California Institute for Regenerative Medicine offers granted a $5 générique à vendre http://zithromax-en-ligne.com .6 million Strategic Partnership Award to fund clinical studies at City of Hope to create a potentially curative ZFP Therapeutic for HIV/AIDS based on the application of Sangamo's zinc finger nuclease genome-editing technology in hematopoietic stem/progenitor cells . Zaia, M.D., Professor & Chair, Section of Virology, Beckman Research Institute of City of Hope and a member of the clinical group which will be conducting the pilot scientific trial of the ZFP Therapeutic.